Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
34 participants
INTERVENTIONAL
2007-09-03
2018-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Weight Changes in Parkinsonian Patients, Treated With Deep Brain Stimulation
NCT00221793
Deep Brain Stimulation and Digestive Symptomatology
NCT00639275
Combined Deep Brain Stimulation in Parkinson's Disease
NCT05415774
Electrophysiological Activity of the Subthalamic Nucleus During the Processing of Emotional and Motivational Information
NCT01537224
Psychiatry Study: Parkinson Disease
NCT02893449
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Clinical examination
* Autoevaluation dietary questionnaire
* Biological tests
* Study in calorimetry chamber (only in Clermont-Ferrand centre)
* Heart rate recorded during 7 days in usual conditions of life
* Energy expenditure recorded during 14 days in usual conditions of life with normalized water (18O 10 %) and Deuterium oxide (99.94 %D)
* Acute Ldopa challenge (in both conditions of dopa and stim)
* Apathy evaluation
* Body weight, and body compositions measurements
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
PREVENTION
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Energy metabolism by chronic bilateral subthalamic stimulation
Patients will be studied before and after STN-DBS surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of Parkinson' disease established for 5 years at least
* Ldopa effect \> 50 %
* Hoehn and Yarh score \> 2.5 in On phase
Exclusion Criteria
* Biological analysis abnormal
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Clermont-Ferrand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
CHU Clermont-Ferrand
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Franck Durif, Pr
Role: PRINCIPAL_INVESTIGATOR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU
Clermont-Ferrand, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHU-0024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.